Press

Press

Pressfishnyc222024-04-13T17:20:17-04:00

Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine
April 12, 2024

ASCO Publications
Advocates say new labels on some chemotherapy drugs aren’t strong enough
April 1, 2024

WMUK
A quick test could protect against fatal chemo overdose, yet few doctors use it
March 27, 2024

NBC News
FDA Updates Fluorouracil Label With DPD Deficiency Risk Information
March 25, 2024

Precision Medicine Online
FDA Approves Safety Label Changes for Fluorouracil Injection
March 22, 2024

Targeted Oncology
This commonly prescribed cancer drug was supposed to help save this doctor’s life. Instead, it killed him
November 27, 2023

CBC
He was killed by a cancer drug that was supposed to extend his life
November 13, 2023

CBC
The Human Cost of Ignoring DPD Deficiency | PGX For Pharmacists
May 2, 2023

Pharmacy Podcast
DPYD Testing: Time to Put Patient Safety First
February 23, 2023

ASCO Publications
Dana-Farber initiative will require pre-emptive genetic testing before 5-FU and/or capecitabine
February 22, 2023

AUDT
Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
August 18, 2022

Precision Medicine Online
Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push for Guideline Changes
August 8, 2022

Precision Medicine Online

Useful links

Why Test
Working with your Oncologist
Treatment Warning Signs
Initiatives
About Us
FAQs
Contact

Subscribe to the newsletter

AUDT is a 501(c)(3) non-profit organization.

© Copyright 2024 | All Rights Reserved | Developed by The Media Council